Dexamethasone sodium phosphate for encapsulation into autoerythrocytes clinical trials

An Open-Label Extension Study of EryDex in Patients with Ataxia-Telangiectasia Following Participation in Study IEDAT-04-2022 (NEAT)

This study is an extension of a previous trial, looking at the long-term safety of an experimental medicine called EryDex for people with Ataxia-Telangiectasia (A-T). It checks for any side effects and how the medicine affects important body functions.